Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Identification of disease-associated immune cells and inflammatory cytokines in a MATR3 S85C knock-in mouse model of amyotrophic lateral sclerosis
EF 2021-22
Résumé
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that involves the gradual loss of motor neurons, leading to paralysis and death. Although the cause of ALS is unknown, neuroinflammation has been proposed as a possible mechanism leading to ALS. Microglial cells that are part of the innate immune system were found to be significantly increased in the central nervous system (CNS) of ALS patients and mice models. However, inflammation is not limited to these cells as dysregulation of peripheral adaptive immune cells, including B and T cells, may cause a systematic inflammatory response that affects the CNS. However, there is limited data on the role of the adaptive immune system in ALS.Recently, our lab generated a mouse model which recapitulates key features of early-stage ALS including neuromuscular junction defects and motor deficits. Interestingly, I found an increased number of B cells and an upregulation of inflammatory genes in the brains of the mutant mice, supporting the idea that the adaptive immune system may play a critical role in ALS. To further study the role of this system, I will quantify the blood cell populations and examine if they infiltrate skeletal muscle tissues affected in ALS. Additionally, as immune cells release signalling molecules called cytokines, I will determine if the levels of cytokines differ between the mutant and wildtype mice. I hypothesize that a specific combination of immune cells and cytokines will be associated with disease progression, acting as potential biomarkers for ALS. Thus, identification of these specific and sensitive biomarkers could be used to diagnose ALS at an early stage and enable the development of early therapeutic intervention strategies.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
466605
Name
Lee Jooyun
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Identification of disease-associated immune cells and inflammatory cytokines in a MATR3 S85C knock-in mouse model of amyotrophic lateral sclerosis
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Amyotrophic Lateral Sclerosis; Cytokines; Immune System; Knock-In Mouse Model; Matr3; Neurodegeneration; Neuroinflammation; Single Cell Transcriptomic Profiling
Abstract
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that involves the gradual loss of motor neurons, leading to paralysis and death. Although the cause of ALS is unknown, neuroinflammation has been proposed as a possible mechanism leading to ALS. Microglial cells that are part of the innate immune system were found to be significantly increased in the central nervous system (CNS) of ALS patients and mice models. However, inflammation is not limited to these cells as dysregulation of peripheral adaptive immune cells, including B and T cells, may cause a systematic inflammatory response that affects the CNS. However, there is limited data on the role of the adaptive immune system in ALS.Recently, our lab generated a mouse model which recapitulates key features of early-stage ALS including neuromuscular junction defects and motor deficits. Interestingly, I found an increased number of B cells and an upregulation of inflammatory genes in the brains of the mutant mice, supporting the idea that the adaptive immune system may play a critical role in ALS. To further study the role of this system, I will quantify the blood cell populations and examine if they infiltrate skeletal muscle tissues affected in ALS. Additionally, as immune cells release signalling molecules called cytokines, I will determine if the levels of cytokines differ between the mutant and wildtype mice. I hypothesize that a specific combination of immune cells and cytokines will be associated with disease progression, acting as potential biomarkers for ALS. Thus, identification of these specific and sensitive biomarkers could be used to diagnose ALS at an early stage and enable the development of early therapeutic intervention strategies.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Lee, Jooyun
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~